Task: Answer the multiple-choice question.
Question: Which drug exhibits a -1.309% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, c, or d without using any other words.
Options:
a.) Cc1cc(C)n(C2CC(=O)N(c3ccccc3)C2=O)n1
b.) Cc1ccc(OCC(=O)Nc2nnc(S(=O)(=O)N3CCCCCC3)s2)cc1C
c.) COCNc1nc(OCC#N)nc(N(C)C)n1
d.) NC(=O)c1oc2ccccc2c1NC(=O)C1CCCCC1
Answer: a. Cc1cc(C)n(C2CC(=O)N(c3ccccc3)C2=O)n1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Cc1cc(C)n(C2CC(=O)N(c3ccccc3)C2=O)n1
Cc1cc(C)n(C2CC(=O)N(c3ccccc3)C2=O)n1
3-(3,5-dimethylpyrazol-1-yl)-1-phenylpyrrolidine-2,5-dione